Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Long-Term Perforomist in COPD
NCT01488019Phase 4Completed
- Sponsor
- Dey
- Start
- Mar 2012
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of formoterol in chronic obstructive pulmonary disease (COPD), sponsored by Dey. Started Mar 2012; status: completed.
02
Drugs
formoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01488019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01488019.